Filing Details

Accession Number:
0001493152-21-014015
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-10 16:01:44
Reporting Period:
2021-06-03
Accepted Time:
2021-06-10 16:01:44
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
868278 Prophase Labs Inc. PRPH Pharmaceutical Preparations (2834) 232577138
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1457896 William Ted Karkus 711 Stewart Ave, Suite 200
Garden City, NY 11530
Ceo & Chairman Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.005 Acquisiton 2021-06-03 33,943 $5.07 2,333,471 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The transaction reported herein was an inadvertent purchase of Issuer common stock pursuant to an automatic broker-administered dividend reinvestment program. The dividend reinvestment feature of the reporting person's brokerage account has since been removed.